Michael Bilous

13.2k total citations · 5 hit papers
70 papers, 9.4k citations indexed

About

Michael Bilous is a scholar working on Oncology, Cancer Research and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Michael Bilous has authored 70 papers receiving a total of 9.4k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Oncology, 28 papers in Cancer Research and 24 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Michael Bilous's work include HER2/EGFR in Cancer Research (33 papers), Breast Cancer Treatment Studies (26 papers) and Monoclonal and Polyclonal Antibodies Research (22 papers). Michael Bilous is often cited by papers focused on HER2/EGFR in Cancer Research (33 papers), Breast Cancer Treatment Studies (26 papers) and Monoclonal and Polyclonal Antibodies Research (22 papers). Michael Bilous collaborates with scholars based in Australia, United States and Canada. Michael Bilous's co-authors include Wedad Hanna, Giuseppe Viale, Mitch Dowsett, John M.S. Bartlett, Patricia A. Spears, Patrick L. Fitzgibbons, Antonio C. Wolff, Pamela B. Mangu, Gail H. Vance and Kimberly H. Allison and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Cancer Research.

In The Last Decade

Michael Bilous

68 papers receiving 9.2k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update

2013 3.1k citations Antonio C. Wolff, M. Elizabeth Hammond et al. Journal of Clinical Oncology profile →
Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update

2018 1.5k citations Antonio C. Wolff, M. Elizabeth Hammond et al. Journal of Clinical Oncology profile →
Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update

2013 1.3k citations Antonio C. Wolff, M. Elizabeth Hammond et al. profile →
Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update

2018 1.0k citations Antonio C. Wolff, M. Elizabeth Hammond et al. profile →
HER2 testing in gastric cancer: a practical approach

2012 448 citations Josef Rüschoff, Wedad Hanna et al. Modern Pathology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael Bilous Australia	27	6.3k	4.0k	3.0k	2.1k	1.9k	70	9.4k
Patrick L. Fitzgibbons United States	35	8.2k 1.3×	6.2k 1.5×	3.0k 1.0×	2.7k 1.3×	2.6k 1.3×	89	13.8k
Jens Huober Germany	47	8.6k 1.4×	6.0k 1.5×	1.7k 0.6×	1.7k 0.8×	3.3k 1.7×	321	12.1k
Jelle Wesseling Netherlands	55	4.3k 0.7×	5.0k 1.2×	2.6k 0.9×	3.3k 1.6×	1.5k 0.7×	281	10.7k
Holger Eidtmann Germany	40	6.6k 1.0×	5.1k 1.3×	1.7k 0.6×	1.1k 0.5×	1.3k 0.7×	123	8.7k
Jean‐Yves Pierga France	59	8.0k 1.3×	6.3k 1.6×	1.1k 0.4×	2.3k 1.1×	3.5k 1.8×	331	12.0k
Johannes L. Peterse Netherlands	50	4.9k 0.8×	4.8k 1.2×	1.3k 0.4×	2.9k 1.4×	1.1k 0.6×	97	9.9k
Gottfried E. Konecny United States	38	4.7k 0.7×	3.2k 0.8×	1.3k 0.4×	2.4k 1.2×	1.1k 0.6×	158	7.8k
Jean F. Simpson United States	42	3.0k 0.5×	2.4k 0.6×	1.2k 0.4×	1.9k 0.9×	790 0.4×	111	6.5k
Christoph Thomssen Germany	53	4.9k 0.8×	4.5k 1.1×	810 0.3×	2.2k 1.1×	1.2k 0.6×	281	8.4k
Serban Dan Costa Germany	37	4.8k 0.8×	4.2k 1.1×	1.3k 0.4×	1.3k 0.6×	978 0.5×	103	7.6k

Countries citing papers authored by Michael Bilous

Since Specialization

Citations

This map shows the geographic impact of Michael Bilous's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Bilous with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Bilous more than expected).

Fields of papers citing papers by Michael Bilous

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Bilous. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Bilous. The network helps show where Michael Bilous may publish in the future.

Co-authorship network of co-authors of Michael Bilous

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Bilous. A scholar is included among the top collaborators of Michael Bilous based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Bilous. Michael Bilous is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wolff, Antonio C., M. Elizabeth Hammond, Kimberly H. Allison, et al.. (2018). Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update. Journal of Clinical Oncology. 36(20). 2105–2122. 1545 indexed citations breakdown →

Kumarasinghe, M. Priyanthi, Adrienne Morey, Michael Bilous, et al.. (2017). HER2 testing in advanced gastric and gastro-oesophageal cancer: analysis of an Australia-wide testing program. Pathology. 49(6). 575–581. 10 indexed citations

Kim, Kyoung‐Mee, Michael Bilous, Kent‐Man Chu, et al.. (2014). Human epidermal growth factor receptor 2 testing in gastric cancer: Recommendations of an A sia‐ P acific T ask F orce. Asia-Pacific Journal of Clinical Oncology. 10(4). 297–307. 38 indexed citations

Fox, Stephen B., M. Priyanthi Kumarasinghe, Jane E. Armes, et al.. (2012). Gastric HER2 Testing Study (GaTHER). The American Journal of Surgical Pathology. 36(4). 577–582. 35 indexed citations

McCarthy, Nicole, Gillian Mitchell, Michael Bilous, Nicholas Wilcken, & Geoffrey J. Lindeman. (2012). Triple‐negative breast cancer: making the most of a misnomer. Asia-Pacific Journal of Clinical Oncology. 8(2). 145–155. 9 indexed citations

Houssami, Nehmat, Petra Macaskill, Rosemary L. Balleine, Michael Bilous, & Mark D. Pegram. (2011). HER2 discordance between primary breast cancer and its paired metastasis: tumor biology or test artefact? Insights through meta-analysis. Breast Cancer Research and Treatment. 129(3). 659–674. 91 indexed citations

Bilous, Michael. (2010). Breast core needle biopsy: issues and controversies. Modern Pathology. 23. S36–S45. 41 indexed citations

Léary, Alexandra, Wedad Hanna, Marc J. van de Vijver, et al.. (2009). Value and Limitations of Measuring HER-2 Extracellular Domain in the Serum of Breast Cancer Patients. Journal of Clinical Oncology. 27(10). 1694–1705. 57 indexed citations

Palma, Silvana Di, Nadine Collins, Michael Bilous, et al.. (2008). A quality assurance exercise to evaluate the accuracy and reproducibility of chromogenic in situ hybridisation for HER2 analysis in breast cancer. Journal of Clinical Pathology. 61(6). 757–760. 13 indexed citations

10.

Houssami, Nehmat, Stefano Ciatto, Michael Bilous, Vania Vezzosi, & Simonetta Bianchi. (2007). Borderline breast core needle histology: predictive values for malignancy in lesions of uncertain malignant potential (B3). British Journal of Cancer. 96(8). 1253–1257. 107 indexed citations

11.

Bilous, Michael, Adrienne Morey, Jane E. Armes, Margaret C. Cummings, & Glenn Francis. (2006). Chromogenic in situ hybridisation testing for HER2 gene amplification in breast cancer produces highly reproducible results concordant with fluorescence in situ hybridisation and immunohistochemistry. Pathology. 38(2). 120–124. 32 indexed citations

12.

Chua, Boon, Owen Ung, Richard Taylor, et al.. (2001). Treatment implications of a positive sentinel lymph node biopsy for patients with early-stage breast carcinoma. Cancer. 92(7). 1769–1774. 28 indexed citations

13.

Wong, Angela Y., Elizabeth Salisbury, & Michael Bilous. (2000). Recent Developments in Stereotactic Breast Biopsy Methodologies: An Update for the Surgical Pathologist. Advances in Anatomic Pathology. 7(1). 26–35. 8 indexed citations

14.

Kricker, Anne, et al.. (1999). An audit of breast cancer pathology reporting in Australia in 1995. British Journal of Cancer. 80(3-4). 563–568. 19 indexed citations

15.

Barraclough, Bruce, et al.. (1996). PROGNOSTIC SIGNIFICANCE OF c‐erbB‐2 ONCOGENE IN AXILLARY NODE‐NEGATIVE BREAST CANCER. Australian and New Zealand Journal of Surgery. 66(2). 64–70. 12 indexed citations

16.

Pendlebury, Susan, Michael Bilous, & Allan O. Langlands. (1995). Sarcomas followig radiation therapy for breast cancer: A report of three cases and a review of the literature. International Journal of Radiation Oncology*Biology*Physics. 31(2). 405–410. 46 indexed citations

17.

Bilous, Michael, et al.. (1995). Adequacy of histopathology reports for breast cancer in New South Wales. Pathology. 27(4). 306–311. 7 indexed citations

18.

Katelaris, Connie, et al.. (1993). Orofacial sensitivity reactions and the role of dietary components. Case reports. Australian Dental Journal. 38(4). 287–291. 30 indexed citations

19.

Schoeman, Mark, Philip I. Craig, Christopher Liddle, et al.. (1990). Chronic non‐A, non‐B hepatitis: lack of correlation between biochemical and morphological activity, and effects of immunosuppressive therapy on disease progression. Australian and New Zealand Journal of Medicine. 20(1). 56–62. 34 indexed citations

20.

Williams, Stephen J., Philip I. Craig, W. G. E. Cooksley, et al.. (1990). Randomised controlled trial of recombinant human interferon ‐αA for chronic active hepatitis B. Australian and New Zealand Journal of Medicine. 20(1). 9–19. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact